A comprehensive view of u.s. food and drug administration (fda). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AbbVie reports FDA has requested further information on subcutaneous pump used in its ABBV-951 combination therapy to treat Parkinson’s disease; treatment uses foscarbidopa and foslevodopa along with pump device

FDA advisor committee supports conditional clearance of Biogen’s tofersen ALS drug; tofersen treats ALS caused by SOD1 gene mutation, which is estimated to be responsible for less than 500 of the approximately 30,000 ALS cases in the US

Ascend Labs recalls 10 lots of dabigatran etexilate anticoagulant capsules in US after routine test finds suspected carcinogen N-nitroso-dabigatran; products shipped between June 2022 and October 2022

China approves its first mRNA vaccine, a domestic shot made by CSPC Pharmaceutical reports Bloomberg; FDA may make decision on new round of booster shots for people 65 years old and older in coming weeks reports WSJ

Private-label OTC provider Granules Consumer Health completes audit by US FDA with zero 483 observations at its packaging facility in Manassas, Virginia; facility is spread over 79,000 sq. ft. and has several packaging suites to service customer needs

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count